🚀 VC round data is live in beta, check it out!
Geratherm Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Geratherm Medical and similar public comparables like Labo Euromedis, ViroGates, Advanced Medical, Wellgistics Health and more.
Geratherm Medical Overview
About Geratherm Medical
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Founded
1990
HQ
Employees
226
Website
Sectors
Financials (LTM)
EV
$9M
Geratherm Medical Financials
Geratherm Medical reported last 12-month revenue of $19M and EBITDA of $2M.
In the same LTM period, Geratherm Medical generated $2M in EBITDA and $141K in net income.
Revenue (LTM)
Geratherm Medical P&L
In the most recent fiscal year, Geratherm Medical reported revenue of $24M and EBITDA of $4M.
Geratherm Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $19M | XXX | $24M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $15M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 63% | XXX | XXX | XXX |
| EBITDA | $2M | XXX | $4M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $141K | XXX | $830K | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Geratherm Medical Stock Performance
Geratherm Medical has current market cap of $17M, and enterprise value of $9M.
Market Cap Evolution
Geratherm Medical's stock price is $3.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $17M | 0.0% | XXX | XXX | XXX | $0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGeratherm Medical Valuation Multiples
Geratherm Medical trades at 0.5x EV/Revenue multiple, and 4.5x EV/EBITDA.
EV / Revenue (LTM)
Geratherm Medical Financial Valuation Multiples
As of April 20, 2026, Geratherm Medical has market cap of $17M and EV of $9M.
Equity research analysts estimate Geratherm Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Geratherm Medical has a P/E ratio of 122.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBIT | 50.9x | XXX | 4.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.6x | XXX | XXX | XXX |
| P/E | 122.0x | XXX | 20.7x | XXX | XXX | XXX |
| EV/FCF | 8.2x | XXX | 6.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Geratherm Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Geratherm Medical Margins & Growth Rates
Geratherm Medical's revenue in the last 12 month grew by 6%.
Geratherm Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Geratherm Medical's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Geratherm Medical's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Geratherm Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | (23%) | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 21% | XXX | (47%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Geratherm Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Geratherm Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Labo Euromedis | XXX | XXX | XXX | XXX | XXX | XXX |
| ViroGates | XXX | XXX | XXX | XXX | XXX | XXX |
| Advanced Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Boule Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Geratherm Medical M&A Activity
Geratherm Medical acquired XXX companies to date.
Last acquisition by Geratherm Medical was on XXXXXXXX, XXXXX. Geratherm Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Geratherm Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGeratherm Medical Investment Activity
Geratherm Medical invested in XXX companies to date.
Geratherm Medical made its latest investment on XXXXXXXX, XXXXX. Geratherm Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Geratherm Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Geratherm Medical
| When was Geratherm Medical founded? | Geratherm Medical was founded in 1990. |
| Where is Geratherm Medical headquartered? | Geratherm Medical is headquartered in Germany. |
| How many employees does Geratherm Medical have? | As of today, Geratherm Medical has over 226 employees. |
| Is Geratherm Medical publicly listed? | Yes, Geratherm Medical is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Geratherm Medical? | Geratherm Medical trades under GME ticker. |
| When did Geratherm Medical go public? | Geratherm Medical went public in 2000. |
| Who are competitors of Geratherm Medical? | Geratherm Medical main competitors are Labo Euromedis, ViroGates, Advanced Medical, Wellgistics Health. |
| What is the current market cap of Geratherm Medical? | Geratherm Medical's current market cap is $17M. |
| What is the current revenue of Geratherm Medical? | Geratherm Medical's last 12 months revenue is $19M. |
| What is the current revenue growth of Geratherm Medical? | Geratherm Medical revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Geratherm Medical? | Current revenue multiple of Geratherm Medical is 0.5x. |
| Is Geratherm Medical profitable? | Yes, Geratherm Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Geratherm Medical? | Geratherm Medical's last 12 months EBITDA is $2M. |
| What is Geratherm Medical's EBITDA margin? | Geratherm Medical's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Geratherm Medical? | Current EBITDA multiple of Geratherm Medical is 4.5x. |
| What is the current FCF of Geratherm Medical? | Geratherm Medical's last 12 months FCF is $1M. |
| What is Geratherm Medical's FCF margin? | Geratherm Medical's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Geratherm Medical? | Current FCF multiple of Geratherm Medical is 8.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.